New Product Submission Checklist - Diagnostic Kits
[Date: yyyy-mm-dd]
| No. | Name of product: | Canadian origin | United States (US) origin | Other countries origin | Check ( |
|---|---|---|---|---|---|
| 1. | Cover letter introducing submission and identifying regulatory contact | ||||
| 2. | Application for Services - Form CFIA/ACIA 4720 and applicable fees | ||||
| 3. | Veterinary Biologics Information - Form CFIA/ACIA 1503 | ||||
| 4. | Application for Permit To Import Veterinary Biologic into Canada - Form CFIA/ACIA 1493 | N/A | |||
| 5. | Copy of Veterinary Biological Establishment License, Manufacturing Authorization, or equivalent | N/A | |||
| 6. | Copy of Veterinary Biological Product License, Marketing Authorization, or equivalent | N/A | |||
| 7. | Justification for use of veterinary biologic in Canada | ||||
| 8. | Outline of Production (OP) *S of C = Summary of Changes |
3 copies | 1 copy + APHIS 2015 and S of C* | 3 copies | |
| 9(A). | Related Outlines of Production | 3 copies of each | 1 of each | 3 copies of each | |
| 9(B). | Referenced Special Outlines (SO) and SOPs (if not already on file at CCVB) | 3 of each if new | 1 of each if new |
3 of each if new | |
| 9(C). | Validation data referenced in OP including data for reference standards and antigen inactivation | ||||
| 10(A). | Draft or final labels | 4 copies of each including insert | 4 copies of each including insert | 4 copies of each including insert | |
| 10(B). | Photocopies of approved labels in the country-of-manufacture for reference only | N/A | |||
| 10(C). | Summary of Product Characteristics | N/A | N/A | ||
| 11(A). | Material of Animal Origin (MAO) - SO | 3 copies | 1 copy (US) 3 copies (Cnd) |
3 copies | |
| 11(B). | MAO - Supplier documents | 1 copy | 1 copy | 1 copy | |
| 12. | Declaration of Compliance regarding TSE (original) | ||||
| 13. | Antigen in the kit | ||||
| 13(A). | Master seed(s): purity and identity | ||||
| 13(B). | Genetic characterization data if biotechnology-derived product | ||||
| 14. | Master cell stock(s): purity and identity | ||||
| 14(A). | Cell lines(s) for viral antigen(s) | ||||
| 14(B). | Hybridomas for monoclonal antibodies | ||||
| 15. | Efficacy/ Performance | ||||
| 15(A). | (A) Preliminary data and proof of concept | N/A | |||
| 15(B-1). | Protocol(s) on reproducibility (Potency) | ||||
| 15(B-2). | Report(s) - Data on reproducibility | Pending: tiered review | Pending: tiered review | ||
| 15)C-1). | Protocol(s) on repeatability | ||||
| 15(C-2). | Report(s) - Data on repeatability | Pending: tiered review | Pending: tiered review | ||
| 15(D-1). | Protocol(s) on field performance | ||||
| 15(D-2). | Report(s) of field performance from different laboratories | Pending: tiered review | Pending: tiered review | ||
| 15(D-3). | Summary report of field performance from the manufacturer | Pending: tiered review | Pending: tiered review | ||
| 15(E). | Estimates of specificity and sensitivity | ||||
| 15(F). | Copies of related correspondence with regulatory authorities of country of origin | N/A | |||
| 16(A). | Non cross-reactivity data | ||||
| 16(B). | Copies of related correspondence with regulatory authorities of country of origin | N/A | |||
| 17. | Guidance on laboratory bio-safety, handling and disposal | ||||
| 18(A). | Stability data to support expiry date | ||||
| 18(B). | Copies of related correspondence with regulatory authorities of country of origin | N/A | |||
| 19. | Environmental assessment | If applicable | If applicable | If applicable | |
| 20. | Template of Manufacturer's Serial Release Test Report Form to CCVB (3 copies) | N/A | |||
| 21 | Results on 3 pre-licensing serials | ||||
| 22. | Other supporting documentation (identify) | If applicable | If applicable | If applicable |
- Date modified: